Tuesday, October 20, 2026
The top medical stories of the day, as they ran.
Morning edition
12 stories
- 1Trump orders NIH women’s health division and White House task forceHealth policy · 6 outlets
- 2FDA approves dostarlimab for certain locally advanced rectal cancersDrugs and FDA · 3 outlets
- 3Study projects more chronic hepatitis B infections if newborn vaccine is delayedVaccines · 3 outlets
- 4Gilead’s oral ulcerative colitis drug shows stronger remission rates than EntyvioResearch · 2 outlets
- 5Jalen Hurts diagnosed with clots in both lungsPublic health · 2 outlets
- 6Mass General Brigham develops AI tools to estimate cancer survival from facial photosResearch · 3 outlets
- 7FDA expands Ryzumvi approval to treat presbyopiaDrugs and FDA · 2 outlets
- 8Merck KGaA agrees to acquire Silence Therapeutics and its RNA drug pipelineIndustry · 3 outlets
- 9Study links ADHD to higher all-cause mortality riskResearch · 2 outlets
- 10FDA warns about Edwards SAPIEN M3 delivery systems after balloon burstsMedical devices · 1 outlet
- 11Philips updates Lumify ultrasound instructions after scan disruptionsMedical devices · 1 outlet
- 12Diabetes conversation cards improved clinician satisfaction but not care fitDiabetes and obesity · 2 outlets
Evening edition
14 stories
- 1Trump creates NIH women’s health division and White House task forceHealth policy · 6 outlets
- 2Study projects more chronic hepatitis B infections if newborn vaccine is delayedVaccines · 3 outlets
- 3FDA approves dostarlimab for selected locally advanced rectal cancersDrugs and FDA · 3 outlets
- 4Jalen Hurts diagnosed with clots in both lungsPublic health · 2 outlets
- 5FDA approves first generic Climara Pro hormone therapy patchDrugs and FDA · 3 outlets
- 6ICER analysis finds launch prices for new medicines remain highHealth policy · 3 outlets
- 7FDA warns about Edwards Commander M systems used with SAPIEN M3Medical devices · 2 outlets
- 8Review links ADHD to higher mortality and medication use to lower riskResearch · 2 outlets
- 9Rapport’s RAP-219 meets primary goal in bipolar mania trialDrugs and FDA · 2 outlets
- 10Disc Medicine says bitopertin met Phase 3 goals for rare light-sensitivity diseaseDrugs and FDA · 2 outlets
- 11FDA approves bepirovirsen combination for some adults with chronic hepatitis BDrugs and FDA · 1 outlet
- 12Democratic senators urge tougher oversight of Medicaid technology contractorsMedicare and Medicaid · 2 outlets
- 13Nova Biomedical removes StatStrip hospital glucose meters over patient-ID riskMedical devices · 1 outlet
- 14FDA grants regular approval to pralsetinib for RET fusion-positive lung cancerDrugs and FDA · 1 outlet